BACKGROUND: Current laboratory biomarkers for lupus nephritis like proteinuria, urine protein to creatinine ratio, creatinine clearance, anti-ds DNA and complement levels lack sensitivity and specificity for predicting disease activity and damage. Free light chains (FLCs) released in circulation during antibodies production play a key role in the pathogenesis of autoimmune diseases. Expression of serum and urinary FLCs in lupus nephritis can act as non-invasive diagnostic and prognostic indicators and alleviate the dependency on the invasive procedure of biopsy to guide management.
AIMS & OBJECTIVES: Present study intends to adjudge the implications of serum and urinary FLCs as non-invasive biomarkers of disease activity in lupus nephritis.
MATERIALS & METHODS: Histomorphological diagnosis of lupus nephritis was done as per ISN-RPS classification. Cases were divided into 2 subgroups, classes I/II and III/IV in accordance with low to high histological grades and activity/chronicity scores. Concurrent serum and urinary FLCs levels were estimated by immunonephelometry and correlated with clinical presentation and histological grades of lupus nephritis. Control cases were selected from a pool of other native renal diseases with a non-immunological basis.
RESULTS: Urinary kappa and lambda FLCs were significantly elevated in lupus nephritis class III/IV as compared to class I/II and controls. Serum kappa FLCs exhibited significant/near significant increments on comparison of classes III/IV and I/II with controls, however, intra-comparison of classes I/II and III/IV was insignificant. Serum lambda FLCs showed significance only for the comparison of class III/IV with controls.
CONCLUSION: Urine FLCs have definite potential to be established as a non-invasive biomarker of activity in lupus nephritis. The role of serum FLCs needs further validation.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
